Antibody-drug conjugates could eventually play a much larger role in cancer treatment – and even replace conventional chemo in some cases, says Lisa Jarvis for Bloomberg Opinion.
Commentary: Targeted cancer drugs finally live up to the hype
- Advertisement -
Most Popular
Commentary: Open source could pop the AI bubble – and soon
Open-source artificial intelligence models are catching up with closed models in terms of performance, says Mark Surman for the Financial Times.
